News

The Shriners Hospitals for Children – Canada Research Centre celebrates half a century of existence

Its mission: To deliver the best treatments to children in Quebec and around the world 50th anniversary of the Shriners…

1 year ago

PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

MINNEAPOLIS, MN, Aug. 17, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical…

1 year ago

Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

MALVERN, Pa., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (Nasdaq: BXRX), a biotechnology…

1 year ago

Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA to NXP800 for the Treatment of Cholangiocarcinoma

Fort Lee, NJ, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage…

1 year ago

Nanox Announces Second Quarter of 2023 Financial Results and Provides Business Update

Reports progress towards global supply chain development Ended the second quarter of 2023 with cash, cash equivalents, restricted cash and…

1 year ago

Excision BioTherapeutics Announces Gene Therapy Publication of Pre-Clinical Data Supporting its First-in-Class CRISPR-Based Gene Therapy Candidate Designed to Functionally Cure HIV-1

Results demonstrate safety, biodistribution, and on-target editing of simian immunodeficiency virus (SIV) in non-human primatesData are a key component of…

1 year ago

Good Supply’s Fan Favourite Cannabis Strains Just Got ‘Juiced’

The New Fruit-Forward Infused Pre-Roll Series from Best-Selling Cannabis Brand Good Supply Now Available Across CanadaTORONTO, Aug. 17, 2023 (GLOBE…

1 year ago

Coloplast Finance B.V. – Announcement no. 04/2023 – Interim Financial Report 9M 2022/23

9M 2022/23Interim financial results, 9M 2022/231 October 2022 - 30 June 2023 Coloplast delivered Q3 organic growth of 8% and…

1 year ago

Tonix Pharmaceuticals to Present at the August Virtual Investor Summit

CHATHAM, N.J., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products…

1 year ago

Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics

– Company to continue focusing on advancement of SEL-212, a potential treatment for chronic refractory gout; Biologics License Application (BLA)…

1 year ago